Literature DB >> 31339615

Enantioselective Synthesis of Arene cis-Dihydrodiols from 2-Pyrones.

Xiao-Wei Liang1, Yunlong Zhao1, Xu-Ge Si1, Meng-Meng Xu1, Jia-Hao Tan1, Zhi-Mao Zhang1, Cheng-Gong Zheng1, Chao Zheng2, Quan Cai1.   

Abstract

An enantioselective chemical synthesis of arene cis-dihydrodiols has been realized from 2-pyrones through sequential ytterbium-catalyzed asymmetric inverse-electron-demand Diels-Alder (IEDDA) reaction of 2-pyrones and retro-Diels-Alder extrusion of CO2 . By using this strategy, a series of substituted arene cis-dihydrodiols can be obtained efficiently with high enantioselectivity (>99 % ee in many cases). Based on this strategy, efficient and concise asymmetric total syntheses of (+)-MK7607 and 1-epi-(+)-MK7607 were accomplished.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Diels-Alder reaction; asymmetric catalysis; dihydrodiols; retro-Diels-Alder reactions; total synthesis

Year:  2019        PMID: 31339615     DOI: 10.1002/anie.201908284

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  3 in total

1.  Enantioselective construction of cis-hydroindole scaffolds via an asymmetric inverse-electron-demand Diels-Alder reaction: application to the formal total synthesis of (+)-minovincine.

Authors:  Fangqing Zhang; Bing-Tao Ren; Yuqiao Zhou; Yangbin Liu; Xiaoming Feng
Journal:  Chem Sci       Date:  2022-04-15       Impact factor: 9.969

2.  A formal [3 + 3] cycloaddition of allenyl imide and activated ketones for the synthesis of tetrasubstituted 2-pyrones.

Authors:  Yu-Hao Wang; De-Hua Zhang; Ze-Hun Cao; Wang-Lai Li; Yi-Yong Huang
Journal:  RSC Adv       Date:  2021-02-26       Impact factor: 3.361

3.  A pyrone remodeling strategy to access diverse heterocycles: application to the synthesis of fascaplysin natural products.

Authors:  Vignesh Palani; Melecio A Perea; Kristen E Gardner; Richmond Sarpong
Journal:  Chem Sci       Date:  2020-11-27       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.